Antithrombin III and protein C in stable angina pectoris--influence of dietary supplementation with polyunsaturated fatty acids

Scand J Clin Lab Invest. 1988 Sep;48(5):469-73. doi: 10.1080/00365518809085759.

Abstract

The effect on plasma antithrombin III (AT III) and protein C on a supplement with polyunsaturated fatty acids (PUFA's) was investigated in a double-blind study in 36 patients with stable angina pectoris. All participants were given a supplement to their normal diets of vegetable oil (4.8 g n-6 PUFA's) for 4 weeks and were then randomized to the same oil or to fish oil (4.8 g n-3 PUFA's) for 12 weeks. Both oil supplements resulted in a statistically significant decrease in AT III activity, but there were no differences between the two different types of PUFA's. Antithrombin III antigen, protein C antigen or activity did not change significantly after either oil supplement. The background and significance for the decrease in antithrombin III activity induced by n-3 and n-6 PUFA's in patients with ischaemic heart disease is unknown.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angina Pectoris / blood
  • Angina Pectoris / diet therapy*
  • Antithrombin III / analysis*
  • Clinical Trials as Topic
  • Double-Blind Method
  • Fatty Acids, Unsaturated / administration & dosage*
  • Female
  • Fish Oils / administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Plant Oils / administration & dosage
  • Protein C / analysis*
  • Random Allocation

Substances

  • Fatty Acids, Unsaturated
  • Fish Oils
  • Plant Oils
  • Protein C
  • Antithrombin III